VGPR or better were achieved by 28 of 66 individuals (42%); 10 individuals achieved CR. developed to inhibit BCL-2, BH3-mimetics have emerged like a novel class of compounds with beneficial results in different medical settings, including chronic lymphocytic leukemia (CLL). In April 2016, the 1st inhibitor of BCL-2, venetoclax, was authorized by the US Food […]
Category: Histaminergic-Related Compounds
This requirement shall bring about underdiagnosis of BDD, because many patients, despite having severe symptoms, usually do not seek medical help or reveal their symptoms due to shame, limited usage of healthcare, or other reasons
This requirement shall bring about underdiagnosis of BDD, because many patients, despite having severe symptoms, usually do not seek medical help or reveal their symptoms due to shame, limited usage of healthcare, or other reasons. increasing rapidly, further research is necessary on all areas of this disorder, including treatment research, epidemiology research, and investigation of […]